by Sue Robbins | Feb 5, 2020 | Migraine
Adults with Migraine have new reason to be hopeful. 2019 saw FDA approval of new acute Migraine medications, and 2020 will be the year thousands of adults with Migraine with or without aura will get to try new meds like Ubrelvy (ubreogepant). Ubrelvy is an oral CGRP...
by Sue Robbins | Nov 8, 2019 | Migraine
Eli Lilly, Allergan and Biohaven have a lot riding on their forthcoming migraine launches, and now cost-effectiveness watchdog ICER has come out with some less-than-stellar findings from data supporting the drugs. The Institute for Clinical and Economic...
by Dr Robbins | Jul 12, 2019 | Headache Drugs, Migraine
This is a new letter to the editor that I wrote, in the journal Headache; these newer CGRP meds are marvelous for many patients, but the true side effect profile is just evolving: (LETTER FROM THE JOURNAL HEADACHE, JULY, 2019: LAWRENCE ROBBINS,M.D.) Erenumab, the...
by Dr Robbins | Jun 6, 2019 | Headache Drugs, Migraine
Dr Robbins & CGRP Part I We were privileged to have Dr. Lawrence Robbins doing a Facebook Live Chat in our group on May 21, 2019. Dr Robbins talked about the CGRP Medications one year after the first medication was FDA approved, and answered questions about how...
by Dr Robbins | Jun 1, 2019 | Migraine
Dr Larry Robbins from the Robbins Headache Clinic answers questions in a Facebook Live Chat for the CGRP & Migraine Community Group. FAQs from migraine patients about the CGRP medications one year after the first one was FDA approved, and information on how...
